The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma

Clinical trial NCT05025371 · COMPLETED

Trial details

NCT number: NCT05025371
Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreas Cancer, Duct Cell Adenocarcinoma

Start date: 2021-04-01
Primary completion: 2021-08-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.